Gilbert Lynn Marks - Jul 10, 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks
Stock symbol
ANTX
Transactions as of
Jul 10, 2025
Transactions value $
$0
Form type
4
Date filed
7/11/2025, 06:20 PM
Previous filing
May 23, 2025
Next filing
Oct 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Marks Gilbert Lynn Director C/O AN2 THERAPEUTICS, INC., 1800 EL CAMINO REAL, SUITE D, MENLO PARK /s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks 2025-07-11 0001916940

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Award $0 +11.9K +28.61% $0.00 53.4K Jul 10, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.